Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and ... and Victoza are brand-name drugs. There currently isn’t a generic version of either ...

Soliqua 100/33 (insulin glargine/lixisenatide) is a brand-name injection pen that’s prescribed to improve blood sugar levels in adults with type 2 diabetes. The drug’s cost, with and without ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Tirzepatide is the active ingredient in the brand-name drugs Mounjaro® and Zepbound®. Mounjaro is FDA-approved as a diabetes drug but is also prescribed off-label for weight loss, while Zepbound ...

The high price and side effects of Ozempic, the blockbuster diabetes drug also used off label for ... Ozempic, the trade name for semaglutide, is a once-a-week injectable medication in the class ...

Liraglutide, sold under brand name Saxenda by Novo Nordisk, has seen its patents expire. Hims & Hers has secured a core supplier for its generic ... approved as a diabetes medication but sometimes ...

Novo Nordisk's blockbuster diabetes drug ... in July on a once-daily drug for diabetes and obesity called liraglutide, which Novo Nordisk sells under the brand names Saxenda and Victoza.

The company, headquartered in the key swing state of Pennsylvania, has announced the creation of 330 jobs in a significant ...

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss ... Shortly after ...

For many patients on tirzepatide, a transformative medication used for weight loss and diabetes, the end of the drug's shortage was ... while Eli Lilly's brand-name versions, Zepbound and Mounjaro ...

OZEMPIC and other “weight loss” jabs have now been linked to ten deaths in the UK. There have also been 7,228 reports of ...